Item talk:Q168092: Difference between revisions

From geokb
(Added OpenAlex topic data)
 
No edit summary
Line 1: Line 1:
OpenAlex: !!python/object/new:pyalex.api.Topic
{
   dictitems:
  "id": "https://openalex.org/T11280",
    cited_by_count: 453479
   "display_name": "Management and Treatment of Hemophilia",
    created_date: '2024-01-23'
  "description": "This cluster of papers focuses on the management and treatment of hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact on joint health. It covers a wide range of topics such as recombinant factor VIII, factor IX, and the safety and efficacy of various treatment strategies.",
    description: This cluster of papers focuses on the management and treatment of
  "keywords": [
      hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact
     "Hemophilia",
      on joint health. It covers a wide range of topics such as recombinant factor
     "Factor VIII",
      VIII, factor IX, and the safety and efficacy of various treatment strategies.
    "Prophylaxis",
     display_name: Management and Treatment of Hemophilia
    "Inhibitors",
     domain:
    "Recombinant Factor VIIa",
      display_name: Health Sciences
    "Gene Therapy",
      id: https://openalex.org/domains/4
    "Joint Disease",
     field:
    "Coagulation Disorders",
      display_name: Medicine
    "Efficacy",
      id: https://openalex.org/fields/27
    "Safety"
     id: https://openalex.org/T11280
  ],
     ids:
  "ids": {
      openalex: https://openalex.org/T11280
    "openalex": "https://openalex.org/T11280",
      wikipedia: https://en.wikipedia.org/wiki/Hemophilia_management
     "wikipedia": "https://en.wikipedia.org/wiki/Hemophilia_management"
     keywords:
  },
    - Hemophilia
  "subfield": {
    - Factor VIII
     "id": "https://openalex.org/subfields/2720",
     - Prophylaxis
     "display_name": "Hematology"
    - Inhibitors
  },
    - Recombinant Factor VIIa
  "field": {
    - Gene Therapy
    "id": "https://openalex.org/fields/27",
    - Joint Disease
    "display_name": "Medicine"
    - Coagulation Disorders
  },
    - Efficacy
  "domain": {
    - Safety
    "id": "https://openalex.org/domains/4",
    siblings:
     "display_name": "Health Sciences"
    - display_name: Acute Myeloid Leukemia
  },
       id: https://openalex.org/T10309
  "siblings": [
    - display_name: Diagnosis and Treatment of Multiple Myeloma
     {
       id: https://openalex.org/T10649
      "id": "https://openalex.org/T10309",
    - display_name: Diseases Related to Blood Group Variants
      "display_name": "Acute Myeloid Leukemia"
       id: https://openalex.org/T11660
    },
    - display_name: Efficacy and Resistance in CML Treatment
    {
       id: https://openalex.org/T11215
       "id": "https://openalex.org/T10649",
    - display_name: Hematopoietic Stem Cell Biology
      "display_name": "Diagnosis and Treatment of Multiple Myeloma"
       id: https://openalex.org/T10345
    },
    - display_name: Hemophagocytic Lymphohistiocytosis and Related Disorders
    {
       id: https://openalex.org/T11616
       "id": "https://openalex.org/T11660",
    - display_name: Hemostatic Agents and Techniques
      "display_name": "Diseases Related to Blood Group Variants"
       id: https://openalex.org/T12548
    },
    - display_name: Platelet Disorders and Thrombosis Mechanisms
    {
       id: https://openalex.org/T10746
       "id": "https://openalex.org/T11215",
    - display_name: Regulation of Iron Metabolism and Anemia
      "display_name": "Efficacy and Resistance in CML Treatment"
       id: https://openalex.org/T10452
    },
    - display_name: Role of Erythropoietin in Disease Treatment and Management
    {
       id: https://openalex.org/T11534
       "id": "https://openalex.org/T10345",
    - display_name: Thrombosis and Coagulation Disorders
      "display_name": "Hematopoietic Stem Cell Biology"
      id: https://openalex.org/T10881
    },
    subfield:
    {
      display_name: Hematology
       "id": "https://openalex.org/T11616",
      id: https://openalex.org/subfields/2720
      "display_name": "Hemophagocytic Lymphohistiocytosis and Related Disorders"
    updated_date: '2024-05-20T05:16:36.394380'
    },
    works_count: 39331
    {
       "id": "https://openalex.org/T12548",
      "display_name": "Hemostatic Agents and Techniques"
    },
    {
       "id": "https://openalex.org/T10746",
      "display_name": "Platelet Disorders and Thrombosis Mechanisms"
    },
    {
       "id": "https://openalex.org/T10452",
      "display_name": "Regulation of Iron Metabolism and Anemia"
    },
    {
       "id": "https://openalex.org/T11534",
      "display_name": "Role of Erythropoietin in Disease Treatment and Management"
    },
    {
       "id": "https://openalex.org/T10881",
      "display_name": "Thrombosis and Coagulation Disorders"
    }
  ],
  "works_count": 39708,
  "cited_by_count": 513035,
  "updated_date": "2024-08-26T05:22:20.118696",
  "created_date": "2024-01-23"
}

Revision as of 14:10, 30 August 2024

{

 "id": "https://openalex.org/T11280",
 "display_name": "Management and Treatment of Hemophilia",
 "description": "This cluster of papers focuses on the management and treatment of hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact on joint health. It covers a wide range of topics such as recombinant factor VIII, factor IX, and the safety and efficacy of various treatment strategies.",
 "keywords": [
   "Hemophilia",
   "Factor VIII",
   "Prophylaxis",
   "Inhibitors",
   "Recombinant Factor VIIa",
   "Gene Therapy",
   "Joint Disease",
   "Coagulation Disorders",
   "Efficacy",
   "Safety"
 ],
 "ids": {
   "openalex": "https://openalex.org/T11280",
   "wikipedia": "https://en.wikipedia.org/wiki/Hemophilia_management"
 },
 "subfield": {
   "id": "https://openalex.org/subfields/2720",
   "display_name": "Hematology"
 },
 "field": {
   "id": "https://openalex.org/fields/27",
   "display_name": "Medicine"
 },
 "domain": {
   "id": "https://openalex.org/domains/4",
   "display_name": "Health Sciences"
 },
 "siblings": [
   {
     "id": "https://openalex.org/T10309",
     "display_name": "Acute Myeloid Leukemia"
   },
   {
     "id": "https://openalex.org/T10649",
     "display_name": "Diagnosis and Treatment of Multiple Myeloma"
   },
   {
     "id": "https://openalex.org/T11660",
     "display_name": "Diseases Related to Blood Group Variants"
   },
   {
     "id": "https://openalex.org/T11215",
     "display_name": "Efficacy and Resistance in CML Treatment"
   },
   {
     "id": "https://openalex.org/T10345",
     "display_name": "Hematopoietic Stem Cell Biology"
   },
   {
     "id": "https://openalex.org/T11616",
     "display_name": "Hemophagocytic Lymphohistiocytosis and Related Disorders"
   },
   {
     "id": "https://openalex.org/T12548",
     "display_name": "Hemostatic Agents and Techniques"
   },
   {
     "id": "https://openalex.org/T10746",
     "display_name": "Platelet Disorders and Thrombosis Mechanisms"
   },
   {
     "id": "https://openalex.org/T10452",
     "display_name": "Regulation of Iron Metabolism and Anemia"
   },
   {
     "id": "https://openalex.org/T11534",
     "display_name": "Role of Erythropoietin in Disease Treatment and Management"
   },
   {
     "id": "https://openalex.org/T10881",
     "display_name": "Thrombosis and Coagulation Disorders"
   }
 ],
 "works_count": 39708,
 "cited_by_count": 513035,
 "updated_date": "2024-08-26T05:22:20.118696",
 "created_date": "2024-01-23"

}